Skip to main content

Table 4 Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form Scoresa Over Time, Paliperidone Palmitate Group

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

  Week 5 Week 13 Week 25
All patients (observed cases)
 Total score, n 67 59 45
  Mean (SD) 49.6 (10.1) 48.0 (12.8) 49.6 (12.3)
 Satisfaction with Medication, n 55 52 44
  Mean (SD) 3.6 (0.9) 3.7 (1.1) 3.6 (1.2)
 Overall Life Satisfaction, n 67 59 45
  Mean (SD) 3.9 (1.0) 3.5 (1.2) 3.6 (1.2)
Patients who completed 25 weeks of treatmentb
 Total score, n 45 45 45
  Mean (SD)a 49.2 (10.3) 47.8 (13.5) 49.6 (12.3)
 Satisfaction with Medication, n 36 41 44
  Mean (SD) 3.6 (0.9) 3.7 (1.2) 3.6 (1.1)
 Overall Life Satisfaction, n 45 45 45
  Mean (SD) 3.8 (1.0) 3.5 (1.3) 3.6 (1.2)
  1. aMaximum total score: 70
  2. bAll patients who had Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form data at weeks 5 and 25